We believe in the power of molecular diagnostics to shed light on crucial information for optimal patient care, leading to the best possible outcome for each individual patient around the world. As an essential partner to patients, physicians, researchers, and pharmaceutical companies navigating the complex landscape of diseases, Mirimus is constantly innovating and evolving its laboratory capabilities.
Diagnostics for respiratory and sexually transmitted infections that elevate patient care and improve quality of life.
Detection of type-1 IFN autoantibodies that block early immune response, leading to uncontrolled viral replication and life-threatening viral illness.
Our Brooklyn, New York CLIA-certified lab is a high-throughput facility processing up to 20,000 samples a day. We pioneered saliva testing for infectious disease and can also handle swabs of any kind, blood, and many other human specimens types. Our lab can rapidly be configured to handle a wide range of diagnostic testing, validation, and research study needs.
Get your diagnostic test to market faster!
As a CLIA-certified lab, Mirimus has the experience and ability to help rapidly validate your clinical diagnostic assay as a New York State lab developed test (LDT). Partner with Mirimus to fast track your diagnostic test as a NY State LDT and launch your product quicker.
Mirimus revolutionized COVID-19 testing with our innovative SalivaClear solution. This low-cost, high-throughput, non-invasive saliva test empowered communities to safely reopen workplaces and schools. We're proud to have helped thousands return to normalcy, and honored to receive the XPRIZE for Rapid COVID Testing for this breakthrough mass testing solution.
760 Parkside Avenue, Suite 206
Brooklyn, NY 11226
+1 (833) MIRIMUS
+1 (833) 647-4687
